Functional alterations in endothelial NO, PGI2 and EDHF pathways in aorta in ApoE/LDLR-/- mice

Gábor Csányi, Mariusz Gajda, Magdalena Franczyk-Zarow, Renata Kostogrys, Pawel Gwoźdź, Lukasz Mateuszuk, Magdalena Sternak, Luiza Wojcik, Teresa Zalewska, Michal Walski, Stefan Chlopicki

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Adequate endothelial production of nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF), and prostacyclin (PGI2) is critical to the maintenance of vascular homeostasis. However, it is not clear whether alterations in each of these vasodilatory pathways contribute to the impaired endothelial function in murine atherosclerosis. In the present study, we analyze the alterations in NO-, EDHF- and PGI2-dependent endothelial function in the thoracic aorta in relation to the development of atherosclerotic plaques in apoE/LDLR-/- mice. We found that in the aorta of 2-month-old apoE/LDLR-/- mice there was no lipid deposition, subendothelial macrophage accumulation; and matrix metalloproteinase (MMP) activity was low, consistent with the absence of atherosclerotic plaques. Interestingly, at this stage the endothelium was already activated and hypertrophic as evidenced by electron microscopy, while acetylcholine-induced NO-dependent relaxation in the thoracic aorta was impaired, with concomitant upregulation of cyclooxygenase-2 (COX-2)/PGI2 and EDHF (epoxyeicosatrienoic acids, EETs) pathways. In the aorta of 3-6-month-old apoE/LDLR-/- mice, lipid deposition, macrophage accumulation and MMP activity in the intima were gradually increased, while impairment of NO-dependent function and compensatory upregulation of COX-2/PGI2 and EDHF pathways were more accentuated. These results suggest that impairment of NO-dependent relaxation precedes the development of atherosclerosis in the aorta and early upregulation of COX-2/PGI2 and EDHF pathways may compensate for the loss of the biological activity of NO.

Original languageEnglish (US)
Pages (from-to)107-115
Number of pages9
JournalProstaglandins and Other Lipid Mediators
Volume98
Issue number3-4
DOIs
StatePublished - Aug 1 2012

Fingerprint

Apolipoproteins E
Epoprostenol
Aorta
Nitric Oxide
Endothelium
Cyclooxygenase 2
Up-Regulation
Macrophages
Atherosclerotic Plaques
Matrix Metalloproteinases
Thoracic Aorta
Atherosclerosis
Lipids
Bioactivity
Electron microscopy
Acetylcholine
Blood Vessels
Electron Microscopy
Homeostasis
Maintenance

Keywords

  • Atherosclerosis
  • EDHF
  • Endothelial dysfunction
  • Gene-targeted mice
  • Nitric oxide
  • Prostacyclin

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Cite this

Functional alterations in endothelial NO, PGI2 and EDHF pathways in aorta in ApoE/LDLR-/- mice. / Csányi, Gábor; Gajda, Mariusz; Franczyk-Zarow, Magdalena; Kostogrys, Renata; Gwoźdź, Pawel; Mateuszuk, Lukasz; Sternak, Magdalena; Wojcik, Luiza; Zalewska, Teresa; Walski, Michal; Chlopicki, Stefan.

In: Prostaglandins and Other Lipid Mediators, Vol. 98, No. 3-4, 01.08.2012, p. 107-115.

Research output: Contribution to journalArticle

Csányi, G, Gajda, M, Franczyk-Zarow, M, Kostogrys, R, Gwoźdź, P, Mateuszuk, L, Sternak, M, Wojcik, L, Zalewska, T, Walski, M & Chlopicki, S 2012, 'Functional alterations in endothelial NO, PGI2 and EDHF pathways in aorta in ApoE/LDLR-/- mice', Prostaglandins and Other Lipid Mediators, vol. 98, no. 3-4, pp. 107-115. https://doi.org/10.1016/j.prostaglandins.2012.02.002
Csányi, Gábor ; Gajda, Mariusz ; Franczyk-Zarow, Magdalena ; Kostogrys, Renata ; Gwoźdź, Pawel ; Mateuszuk, Lukasz ; Sternak, Magdalena ; Wojcik, Luiza ; Zalewska, Teresa ; Walski, Michal ; Chlopicki, Stefan. / Functional alterations in endothelial NO, PGI2 and EDHF pathways in aorta in ApoE/LDLR-/- mice. In: Prostaglandins and Other Lipid Mediators. 2012 ; Vol. 98, No. 3-4. pp. 107-115.
@article{88676725e5b5406b9dd31e25d71b6b74,
title = "Functional alterations in endothelial NO, PGI2 and EDHF pathways in aorta in ApoE/LDLR-/- mice",
abstract = "Adequate endothelial production of nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF), and prostacyclin (PGI2) is critical to the maintenance of vascular homeostasis. However, it is not clear whether alterations in each of these vasodilatory pathways contribute to the impaired endothelial function in murine atherosclerosis. In the present study, we analyze the alterations in NO-, EDHF- and PGI2-dependent endothelial function in the thoracic aorta in relation to the development of atherosclerotic plaques in apoE/LDLR-/- mice. We found that in the aorta of 2-month-old apoE/LDLR-/- mice there was no lipid deposition, subendothelial macrophage accumulation; and matrix metalloproteinase (MMP) activity was low, consistent with the absence of atherosclerotic plaques. Interestingly, at this stage the endothelium was already activated and hypertrophic as evidenced by electron microscopy, while acetylcholine-induced NO-dependent relaxation in the thoracic aorta was impaired, with concomitant upregulation of cyclooxygenase-2 (COX-2)/PGI2 and EDHF (epoxyeicosatrienoic acids, EETs) pathways. In the aorta of 3-6-month-old apoE/LDLR-/- mice, lipid deposition, macrophage accumulation and MMP activity in the intima were gradually increased, while impairment of NO-dependent function and compensatory upregulation of COX-2/PGI2 and EDHF pathways were more accentuated. These results suggest that impairment of NO-dependent relaxation precedes the development of atherosclerosis in the aorta and early upregulation of COX-2/PGI2 and EDHF pathways may compensate for the loss of the biological activity of NO.",
keywords = "Atherosclerosis, EDHF, Endothelial dysfunction, Gene-targeted mice, Nitric oxide, Prostacyclin",
author = "G{\'a}bor Cs{\'a}nyi and Mariusz Gajda and Magdalena Franczyk-Zarow and Renata Kostogrys and Pawel Gwoźdź and Lukasz Mateuszuk and Magdalena Sternak and Luiza Wojcik and Teresa Zalewska and Michal Walski and Stefan Chlopicki",
year = "2012",
month = "8",
day = "1",
doi = "10.1016/j.prostaglandins.2012.02.002",
language = "English (US)",
volume = "98",
pages = "107--115",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier BV",
number = "3-4",

}

TY - JOUR

T1 - Functional alterations in endothelial NO, PGI2 and EDHF pathways in aorta in ApoE/LDLR-/- mice

AU - Csányi, Gábor

AU - Gajda, Mariusz

AU - Franczyk-Zarow, Magdalena

AU - Kostogrys, Renata

AU - Gwoźdź, Pawel

AU - Mateuszuk, Lukasz

AU - Sternak, Magdalena

AU - Wojcik, Luiza

AU - Zalewska, Teresa

AU - Walski, Michal

AU - Chlopicki, Stefan

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Adequate endothelial production of nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF), and prostacyclin (PGI2) is critical to the maintenance of vascular homeostasis. However, it is not clear whether alterations in each of these vasodilatory pathways contribute to the impaired endothelial function in murine atherosclerosis. In the present study, we analyze the alterations in NO-, EDHF- and PGI2-dependent endothelial function in the thoracic aorta in relation to the development of atherosclerotic plaques in apoE/LDLR-/- mice. We found that in the aorta of 2-month-old apoE/LDLR-/- mice there was no lipid deposition, subendothelial macrophage accumulation; and matrix metalloproteinase (MMP) activity was low, consistent with the absence of atherosclerotic plaques. Interestingly, at this stage the endothelium was already activated and hypertrophic as evidenced by electron microscopy, while acetylcholine-induced NO-dependent relaxation in the thoracic aorta was impaired, with concomitant upregulation of cyclooxygenase-2 (COX-2)/PGI2 and EDHF (epoxyeicosatrienoic acids, EETs) pathways. In the aorta of 3-6-month-old apoE/LDLR-/- mice, lipid deposition, macrophage accumulation and MMP activity in the intima were gradually increased, while impairment of NO-dependent function and compensatory upregulation of COX-2/PGI2 and EDHF pathways were more accentuated. These results suggest that impairment of NO-dependent relaxation precedes the development of atherosclerosis in the aorta and early upregulation of COX-2/PGI2 and EDHF pathways may compensate for the loss of the biological activity of NO.

AB - Adequate endothelial production of nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF), and prostacyclin (PGI2) is critical to the maintenance of vascular homeostasis. However, it is not clear whether alterations in each of these vasodilatory pathways contribute to the impaired endothelial function in murine atherosclerosis. In the present study, we analyze the alterations in NO-, EDHF- and PGI2-dependent endothelial function in the thoracic aorta in relation to the development of atherosclerotic plaques in apoE/LDLR-/- mice. We found that in the aorta of 2-month-old apoE/LDLR-/- mice there was no lipid deposition, subendothelial macrophage accumulation; and matrix metalloproteinase (MMP) activity was low, consistent with the absence of atherosclerotic plaques. Interestingly, at this stage the endothelium was already activated and hypertrophic as evidenced by electron microscopy, while acetylcholine-induced NO-dependent relaxation in the thoracic aorta was impaired, with concomitant upregulation of cyclooxygenase-2 (COX-2)/PGI2 and EDHF (epoxyeicosatrienoic acids, EETs) pathways. In the aorta of 3-6-month-old apoE/LDLR-/- mice, lipid deposition, macrophage accumulation and MMP activity in the intima were gradually increased, while impairment of NO-dependent function and compensatory upregulation of COX-2/PGI2 and EDHF pathways were more accentuated. These results suggest that impairment of NO-dependent relaxation precedes the development of atherosclerosis in the aorta and early upregulation of COX-2/PGI2 and EDHF pathways may compensate for the loss of the biological activity of NO.

KW - Atherosclerosis

KW - EDHF

KW - Endothelial dysfunction

KW - Gene-targeted mice

KW - Nitric oxide

KW - Prostacyclin

UR - http://www.scopus.com/inward/record.url?scp=84864495175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864495175&partnerID=8YFLogxK

U2 - 10.1016/j.prostaglandins.2012.02.002

DO - 10.1016/j.prostaglandins.2012.02.002

M3 - Article

C2 - 22465673

AN - SCOPUS:84864495175

VL - 98

SP - 107

EP - 115

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

IS - 3-4

ER -